Few doctors are following genetic testing guidelines for breast cancer

Advancements in genetic testing have allowed medical professionals to more accurately diagnose breast cancer and get a better idea of which of their patients could benefit from a prescription to buy Tamoxifen. However, few doctors may be using these tools to their fullest.

A recent survey conducted by the Centers for Disease Control and Prevention found that just 41 percent of doctors said they would recommend genetic testing for their breast and ovarian cancer patients, even if they are at high risk due to family history.

The researchers said that this could cause doctors to miss diagnosing women with breast cancer at an early stage, when the condition is most treatable. Furthermore, failing to understand every woman's unique risk factors could lead to the over-testing and treatment of women at low risk.

"Despite the existence of evidence-based guidelines on referral for genetic counseling and testing for hereditary breast and ovarian cancer, many physicians report practices contrary to these recommendations," said Dr. Katrina Trivers, who conducted the study.

The findings suggest that some medical professionals should reconsider the way they test for and treat breast cancer.